Magic bullets from llamas

Daniel J. Leahy

doi:10.1016/j.str.2013.06.008

Magic bullets from llamas

Daniel J. Leahy

Research output: Contribution to journal › Short survey › peer-review

1 Scopus citations

Abstract

Monoclonal antibodies are effective therapies for many disorders, but their nature and use continues to evolve as technologies emerge to improve their drug-like qualities. In this issue of Structure, Schmitz and colleagues report on structural and biophysical characterizations of single-domain "nanobodies" from llamas that target the epidermal growth factor receptor by both old and new mechanisms.

Original language	English (US)
Pages (from-to)	1072-1073
Number of pages	2
Journal	Structure
Volume	21
Issue number	7
DOIs	https://doi.org/10.1016/j.str.2013.06.008
State	Published - Jul 2 2013
Externally published	Yes

ASJC Scopus subject areas

Structural Biology
Molecular Biology

Access to Document

10.1016/j.str.2013.06.008

Cite this

@article{f5d785dfd51c4b4f84a266554db19f50,

title = "Magic bullets from llamas",

abstract = "Monoclonal antibodies are effective therapies for many disorders, but their nature and use continues to evolve as technologies emerge to improve their drug-like qualities. In this issue of Structure, Schmitz and colleagues report on structural and biophysical characterizations of single-domain {"}nanobodies{"} from llamas that target the epidermal growth factor receptor by both old and new mechanisms.",

author = "Leahy, {Daniel J.}",

year = "2013",

month = jul,

day = "2",

doi = "10.1016/j.str.2013.06.008",

language = "English (US)",

volume = "21",

pages = "1072--1073",

journal = "Structure",

issn = "0969-2126",

publisher = "Cell Press",

number = "7",

}

TY - JOUR

T1 - Magic bullets from llamas

AU - Leahy, Daniel J.

PY - 2013/7/2

Y1 - 2013/7/2

N2 - Monoclonal antibodies are effective therapies for many disorders, but their nature and use continues to evolve as technologies emerge to improve their drug-like qualities. In this issue of Structure, Schmitz and colleagues report on structural and biophysical characterizations of single-domain "nanobodies" from llamas that target the epidermal growth factor receptor by both old and new mechanisms.

AB - Monoclonal antibodies are effective therapies for many disorders, but their nature and use continues to evolve as technologies emerge to improve their drug-like qualities. In this issue of Structure, Schmitz and colleagues report on structural and biophysical characterizations of single-domain "nanobodies" from llamas that target the epidermal growth factor receptor by both old and new mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=84879803525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879803525&partnerID=8YFLogxK

U2 - 10.1016/j.str.2013.06.008

DO - 10.1016/j.str.2013.06.008

M3 - Short survey

C2 - 23823325

AN - SCOPUS:84879803525

SN - 0969-2126

VL - 21

SP - 1072

EP - 1073

JO - Structure

JF - Structure

IS - 7

ER -

Magic bullets from llamas

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this